Company / Revenue per Share
Beta Bionics, Inc. Revenue per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$15.04
FY2025
5-year range
$2.26 / $15.04
FY2023-FY2025
Trend
+22.4%
vs FY2024
Sector context
#101 of 153
Health Care
What the data says
At $15.04, Beta Bionics, Inc.'s revenue per share ranks #101 of 153 in the Health Care sector. Improved from $2.26 to $15.04 over the past 2 years.
Based on SEC 10-K filings.
15.04 in FY2025.
Improved from $2.26 to $15.04 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#101 of 153 in Health CareTop 66% of 153This company $15.04 Sector average $124.28
▼
-87.9% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 22.4% year-over-year.
- Ranks #101 out of 153 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.04 | +22.4% |
| FY2024 | $12.28 | +442.9% |
| FY2023 | $2.26 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026